Literature DB >> 33739480

Regulation and accreditation of addictive behaviour apps - navigating the landscape.

Zarnie Khadjesari1, Tracey Brown2, Felix Naughton1.   

Abstract

BACKGROUND: mHealth applications (apps) for addictive behaviours offer widespread provision of digital support, with particular benefits for stigmatised groups and those with poor access to treatment services. Regulation and accreditation may encourage the uptake and use of evidence-based addictive behaviour apps, yet this is a complex and confusing landscape. We navigate international regulatory and accreditation guidance, explore some of the implementation challenges and provide implications for app developers, healthcare professionals, app users. ANALYSIS: We explore the classification of health and wellbeing, blended support and clinical therapy apps as medical devices by country, to help readers navigate the complexity of the guidance. We describe an addictive behaviour app classified as a medical device and explore the innovative approaches to regulation that are currently emerging. We discuss the use of curated online app libraries that adhere to thresholds for characteristics such as quality, user satisfaction or effectiveness, which we hope will become the starting point in the search for suitable apps, rather than commercial app stores. We also explore the ethical concerns associated with apps and how curated libraries address these.
CONCLUSIONS: International regulation of apps as medical devices varies across countries and would benefit from standardisation in a simple, usable and transparent format. Efforts to provide accreditation of non-medical device apps are also variable and public bodies provide mixed messages around endorsement. Healthcare professionals and users are encouraged to use accredited apps for addictive behaviours, where they exist, or explore other forms of digital intervention with a stronger evidence-base. This article is protected by copyright. All rights reserved.

Keywords:  addiction; app accreditation; app regulation; mHealth; medical device

Year:  2021        PMID: 33739480     DOI: 10.1111/add.15484

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  4 in total

1.  Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder.

Authors:  Fulton F Velez; Sam Colman; Laura Kauffman; Charles Ruetsch; Kathryn Anastassopoulos; Yuri A Maricich
Journal:  Clinicoecon Outcomes Res       Date:  2021-10-29

2.  Smartphone Apps for Vaping Cessation: Quality Assessment and Content Analysis.

Authors:  Sherald Sanchez; Anasua Kundu; Elizabeth Limanto; Peter Selby; Neill Bruce Baskerville; Michael Chaiton
Journal:  JMIR Mhealth Uhealth       Date:  2022-03-28       Impact factor: 4.773

3.  Novel Implementation Strategy to Electronically Screen and Signpost Patients to Health Behavior Apps: Mixed Methods Implementation Study (OptiMine Study).

Authors:  Zarnie Khadjesari; Tracey J Brown; Alex T Ramsey; Henry Goodfellow; Sherine El-Toukhy; Lorien C Abroms; Helena Jopling; Arden Dierker Viik; Michael S Amato
Journal:  JMIR Form Res       Date:  2022-07-11

4.  Navigating Medical Device Certification: A Qualitative Exploration of Barriers and Enablers Amongst Innovators, Notified Bodies and Other Stakeholders.

Authors:  Rebecca Baines; Petra Hoogendoorn; Sebastian Stevens; Arunangsu Chatterjee; Liz Ashall-Payne; Tim Andrews; Simon Leigh
Journal:  Ther Innov Regul Sci       Date:  2022-10-04       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.